March is Developmental Disabilities Awareness Month ???? At Scilex, we are committed to inclusive, accessible pain management for all. Many individuals with developmental disabilities face unique challenges in managing pain, and we strive to provide safe, non-opioid solutions to support their well-being. Let’s work together to raise awareness, promote inclusivity, and advance accessible healthcare. #DevelopmentalDisabilitiesAwarenessMonth #Inclusion #AccessibleHealthcare #PainManagement #Scilex
Scilex Holding Company
制药业
Palo Alto,California 3,445 位关注者
Striving to Revolutionize the World of Non-Opioid Pain Management
关于我们
SCILEX HOLDING COMPANY (Nasdaq: SCLX, “Scilex”), is dedicated to the development and commercialization of non-opioid pain management products. We are uncompromising in our focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life. The company’s lead product ZTlido? (lidocaine topical system) 1.8%, is a marketed prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of pain associated with Post-Herpetic Neuralgia (PHN), which is a form of post-shingles nerve pain. ZTlido? possesses novel delivery and adhesion technology designed to address many of the limitations of current prescription lidocaine patches by providing significantly improved adhesion and continuous pain relief. Click here for ZTLido’s Important Safety Information and US Prescribing Information. We have acquired two FDA approved non-opioid pain products, GLOPERBA? and ELYXYB?. GLOPERBA? is indicated for the prophylaxis of gout flares in adults. Elyxyb is indicated for the acute treatment of migraine with or without aura in adults. We launched ELYXYB? in the U.S. in 2023 and launched and began commercializing GLOPERBA? in 2024. SCILEX is committed to harnessing the power of revolutionary delivery technologies designed to safely and effectively provide therapies to patients who need them the most. Our pipeline product candidates are (i) SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (“SEMDEXA?”), a novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain; (ii) SP-103 (lidocaine topical system) 5.4%, (“SP-103”), a next-generation, triple-strength formulation of ZTlido?, has recently completed a Phase 2 trial in acute lower back pain ; Scilex Pharmaceuticals and Semnur Pharmaceuticals are wholly-owned subsidiaries of Scilex Holding Company.
- 网站
-
https://www.scilexholding.com
Scilex Holding Company的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Palo Alto,California
- 类型
- 上市公司
- 创立
- 2019
- 领域
- Pain和non-opioid
地点
Scilex Holding Company员工
动态
-
A huge thank you to the Scilex Holding Company team for coming together to support HealthRIGHT 360 with such enthusiasm! ??? Your dedication in assembling no-sew blankets will provide warmth and comfort to individuals experiencing homelessness in our community. Thanks to your efforts, 12 blankets will be distributed to those in need—a small act of kindness that makes a big difference. We’re grateful for your commitment to giving back and look forward to more impactful moments together! #LifeScienceCares #ScilexHolding #HealthRIGHT360 #CommunityImpact #GivingBack
-
-
March is National Kidney Month – Prioritizing Kidney Health & Pain Management ???? At Scilex, we recognize the importance of kidney health and its connection to overall well-being. Millions of people are affected by kidney disease, and managing chronic pain safely is essential for protecting kidney function. As a leader in non-opioid pain management, we are committed to developing safer alternatives that help patients manage pain without compromising kidney health. Many pain medications, especially long-term NSAID and opioid use, can put stress on the kidneys, making innovative treatment options even more critical. This National Kidney Month, we encourage everyone to take steps toward kidney health—stay hydrated, maintain a balanced diet, and explore pain management solutions that prioritize both effectiveness and safety. Let’s work together to raise awareness and promote healthier choices. Your kidneys matter! #NationalKidneyMonth #KidneyHealth #PainManagement #NonOpioid #Scilex #Innovation #HealthMatters
-
-
?????????????? ???????? ?????????? ?????????????? ???? ??????????????????????. No more tablet splitting. No more spacing out doses. No more struggling to remember your dosing schedule—with low-dose GLOPERBA! ? For decades, patients have only had access to 0.6 mg colchicine tablets and capsules, making dose adjustments challenging and increasing the risk of over- or underdosing. Now, with?????????????????, precision dosing below 0.6 mg is finally possible!?????-???????? ????????????????,?including those with moderate to severe kidney disease, stomach or intestinal sensitivity, especially older adults, can get the strength of colchicine they need—at a dose they can safely tolerate. ? With a?"???????? ??????????"?dose of colchicine, it’s easier to stay with treatment. ?????? ???????? ???????????? ?????????? ??????-???????? ???????????????? ??????????. ? You can find more information on?www.gloperba.com
-
-
?? Brain Awareness Week: Advancing Pain Management with Innovation ?? At Scilex, we recognize the critical role brain health plays in overall well-being, especially when it comes to managing pain. Chronic pain affects millions, and its impact on cognitive function, mental health, and daily life is profound. By prioritizing innovative, science-driven therapies, we strive to offer patients safe and effective alternatives that improve quality of life without compromising brain health. Join us in raising awareness and supporting advancements in neuroscience and pain management. Together, we can pave the way for a healthier future. #BrainAwarenessWeek #PainManagement #Neuroscience #Scilex #Innovation
-
-
Today, we celebrate the exceptional women whose talent, dedication, and vision drive our success every day. At Scilex, we recognize that empowering women fuels innovation and strengthens our community. Join us in honoring the remarkable contributions of the women in our team and across the industry—and in championing a future where every woman’s potential is fully realized. #InternationalWomensDay #WomenInPharma #Scilex #Empowerment #Inclusion
-
-
Today, on Employee Appreciation Day, we pause to celebrate the incredible dedication and passion of the Scilex team. Your hard work, innovative spirit, and commitment to excellence drive our success every day. We’re proud to be a pharma company where every voice matters, and each contribution helps shape our future. Thank you for making a difference and for being the heart of Scilex. Here’s to our shared journey of growth, innovation, and making a positive impact on healthcare. #EmployeeAppreciationDay #TeamScilex #Pharma #Innovation #Gratitude
-
-
At Scilex, we know that every voice can spark change. On National Be Heard Day, we’re celebrating the innovation and passion that make small pharma a powerhouse in healthcare. In our close-knit team, every insight counts—from breakthrough ideas to thoughtful questions that challenge the status quo. Today, we invite our employees, partners, and the broader healthcare community to share your perspectives. Let’s come together to fuel progress, improve patient care, and inspire each other to think boldly. Speak up, be heard, and let’s drive change together. #NationalBeHeardDay #HealthcareInnovation #Scilex
-
-
Celebrating Pharmacy Appreciation Month! At Scilex, we recognize and appreciate the dedication of pharmacists and pharmacy professionals who play a crucial role in patient care. Your expertise, commitment, and compassion make a difference in the lives of countless individuals every day. Thank you for your hard work in ensuring patients receive the care they need! #PharmacyAppreciationMonth #ThankYouPharmacists #Scilex
-
-
Scilex would like to express our gratitude to everyone who participated in creating No-Sew Blankets for HealthRIGHT 360 through Life Science Cares. This team-building event started off as a bit of a challenge, but with patience, dedication, and teamwork, we came together to make a real impact. These blankets will be distributed to the unhoused community in San Francisco, providing not just warmth but also essential information on resources and support programs. Thank you all for your enthusiasm and commitment, we look forward to our next opportunity to give back together! #ScilexCares #Teamwork #CommunityImpact #LifeScienceCares #HealthRIGHT360
-